Financhill
Back

Catalyst Pharmaceuticals Stock Price Chart

Buy
71

CPRX
Catalyst Pharmaceuticals

Last Price:
16.80
Seasonality Move:
-1.84%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.

Catalyst Pharmaceuticals Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 16.75 Buy
20-day SMA: 16.29 Buy
50-day SMA: 14.55 Buy
200-day SMA: 10.6 Buy
8-day EMA: 16.73 Buy
20-day EMA: 16.21 Buy
50-day EMA: 15 Buy
200-day EMA: 11.44 Buy

Catalyst Pharmaceuticals Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 58.57 Buy
Chaikin Money Flow: -242061 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.93 - 16.97) Buy
Bollinger Bands (100): (11.7 - 15.58) Buy

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Catalyst Pharmaceuticals Stock

Is Catalyst Pharmaceuticals Stock a Buy?

CPRX Technical Analysis vs Fundamental Analysis

Buy
71
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy or a Sell?

Catalyst Pharmaceuticals Stock Info

Market Cap:
1.75B
Price in USD:
16.80
Share Volume:
968.24K

Catalyst Pharmaceuticals 52-Week Range

52-Week High:
18.39
52-Week Low:
5.24
Buy
71
Catalyst Pharmaceuticals (CPRX) is a Buy

Catalyst Pharmaceuticals Share Price Forecast

Is Catalyst Pharmaceuticals Stock a Buy?

Fundamental Analysis of Catalyst Pharmaceuticals

Is Catalyst Pharmaceuticals a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.17 per share.

Technical Analysis of Catalyst Pharmaceuticals

Should I short Catalyst Pharmaceuticals stock?

* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.